Skip to main content
Top
Published in: Journal of Cancer Education 1/2012

01-03-2012 | Reflections

A Community-Based Transformation

Author: Andrew J. Perrin

Published in: Journal of Cancer Education | Issue 1/2012

Login to get access

Abstract

In the early stages of my medical training I wanted to be an academic. I saw little value in endeavours that extended beyond the tertiary-care hospital. This all changed when I was mandated to complete a community-based oncology research project as part of my second year of medical school. During that project, I had the good fortune to work with a motivated community agency and a strong focus group of individuals who were touched by cancer. This dynamic combination of mentors forced me to reevaluate my earlier assumptions about community-based research, and I ultimately left the project with a stronger sense of how my efforts as a clinician could make an impact in the community, supporting those who in turn support the patient outside of the hospital. Learning that the course of many illnesses is determined at least as much by caregiver support as it is by active intervention by the physician, I finally came to appreciate that community and hospital work support each other in modern medical care. By addressing the social determinants of health, physicians can improve the care of their patients, regardless of their prognosis, and increase the impact that they have on the health of entire families.
Literature
Metadata
Title
A Community-Based Transformation
Author
Andrew J. Perrin
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2012
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0276-1

Other articles of this Issue 1/2012

Journal of Cancer Education 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine